Geldenhuys WJ - Search Results

1

Design and synthesis of small molecule agonists of EphA2 receptor.

Petty A, Idippily N, Bobba V, Geldenhuys WJ, Zhong B, Su B, Wang B. Petty A, et al. Among authors: geldenhuys wj. Eur J Med Chem. 2018 Jan 1;143:1261-1276. doi: 10.1016/j.ejmech.2017.10.026. Epub 2017 Oct 10. Eur J Med Chem. 2018. PMID: 29128116 Free PMC article.

2

Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease.

Geldenhuys WJ, Malan SF, Murugesan T, Van der Schyf CJ, Bloomquist JR. Geldenhuys WJ, et al. Bioorg Med Chem. 2004 Apr 1;12(7):1799-806. doi: 10.1016/j.bmc.2003.12.045. Bioorg Med Chem. 2004. PMID: 15028270

3

Synthesis, biological evaluation, and molecular modeling of novel thioacridone derivatives related to the anticancer alkaloid acronycine.

Dheyongera JP, Geldenhuys WJ, Dekker TG, Van der Schyf CJ. Dheyongera JP, et al. Among authors: geldenhuys wj. Bioorg Med Chem. 2005 Feb 1;13(3):689-98. doi: 10.1016/j.bmc.2004.10.051. Bioorg Med Chem. 2005. PMID: 15653336

4

Structure-activity relationships of pentacycloundecylamines at the N-methyl-d-aspartate receptor.

Geldenhuys WJ, Malan SF, Bloomquist JR, Van der Schyf CJ. Geldenhuys WJ, et al. Bioorg Med Chem. 2007 Feb 1;15(3):1525-32. doi: 10.1016/j.bmc.2006.09.060. Epub 2006 Sep 29. Bioorg Med Chem. 2007. PMID: 17157509

5

Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET.

Geldenhuys WJ, Funk MO, Barnes KF, Carroll RT. Geldenhuys WJ, et al. Bioorg Med Chem Lett. 2010 Feb 1;20(3):819-23. doi: 10.1016/j.bmcl.2009.12.088. Epub 2010 Jan 4. Bioorg Med Chem Lett. 2010. PMID: 20064719

6

Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening.

Geldenhuys WJ, Darvesh AS, Funk MO, Van der Schyf CJ, Carroll RT. Geldenhuys WJ, et al. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5295-8. doi: 10.1016/j.bmcl.2010.06.128. Epub 2010 Jul 1. Bioorg Med Chem Lett. 2010. PMID: 20650633

7

Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.

Geldenhuys WJ, Kuzenko SR, Simmons MA. Geldenhuys WJ, et al. J Med Chem. 2010 Nov 25;53(22):8080-8. doi: 10.1021/jm1010012. Epub 2010 Nov 3. J Med Chem. 2010. PMID: 21047106

8

3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptor.

Geldenhuys WJ, Simmons MA. Geldenhuys WJ, et al. Bioorg Med Chem Lett. 2011 Dec 15;21(24):7405-11. doi: 10.1016/j.bmcl.2011.10.014. Epub 2011 Oct 12. Bioorg Med Chem Lett. 2011. PMID: 22056747

9

A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.

Geldenhuys WJ, Funk MO, Van der Schyf CJ, Carroll RT. Geldenhuys WJ, et al. Bioorg Med Chem Lett. 2012 Feb 1;22(3):1380-3. doi: 10.1016/j.bmcl.2011.12.056. Epub 2011 Dec 16. Bioorg Med Chem Lett. 2012. PMID: 22225638

10

Identification of a class of novel tubulin inhibitors.

Yi X, Zhong B, Smith KM, Geldenhuys WJ, Feng Y, Pink JJ, Dowlati A, Xu Y, Zhou A, Su B. Yi X, et al. Among authors: geldenhuys wj. J Med Chem. 2012 Apr 12;55(7):3425-35. doi: 10.1021/jm300100d. Epub 2012 Apr 2. J Med Chem. 2012. PMID: 22435708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters